Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
NCT ID: NCT02782416
Last Updated: 2016-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
800 participants
INTERVENTIONAL
2014-01-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Waiting for renal transplant_no screening of LTBI
patients with renal failure and are waiting for renal transplant We do routine examination but no LTBI check
No interventions assigned to this group
Not waiting for renal transplant
Dialysis patients who are not waiting for renal transplant
Examination of latent tuberculosis
Status post renal transplant
patients who have received renal transplant
Examination of latent tuberculosis
Waiting for renal transplant_ screening of LTBI
patients with renal failure and are waiting for renal transplant We do routine examination in addition to LTBI check
Examination of latent tuberculosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Examination of latent tuberculosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Waiting renal transplant or status post renal transplant
3. Receiving long term dialysis
Exclusion Criteria
2. Suspected active TB
3. HIV patients
4. Viral hepatitis
5. Using immunosuppressants within 3 months before enrollment
6. Receiving lymphokine therapy
7. Hemoglobin \< 8 g/dL
8. Serum bilirubin \> 2.5 mg/dL
9. AST or ALT \> 2 times of upper normal limit
10. Lactation or pregnancy
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chin-Chung Shu, MD
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chin-Chung Shu, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201309056RINC
Identifier Type: -
Identifier Source: org_study_id